ArticleCancer medicine2022

Downregulation of NCL attenuates tumor formation and growth in HeLa cells by targeting the PI3K/AKT pathway.

Jun Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.